Genetic testing needed to identify high-risk blood cancer earlier

by

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.

Leave A Comment

Your email address will not be published. Required fields are marked *